$LAD
Lithia Motors Inc Stock $lad

$lad Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000102312824000104 Filed on August 08, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$9.221B	$9.232B
YoY Change	11.41%	13.81%
Cost Of Revenue	$7.790B	$7.801B
YoY Change	12.8%	15.65%
Gross Profit	$1.431B	$1.431B
YoY Change	4.38%	4.74%
Gross Profit Margin	15.52%	15.5%
Selling, General & Admin	$943.7M	$973.4M
YoY Change	10.92%	16.06%
% of Gross Profit	65.93%	68.02%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$63.50M	$62.30M
YoY Change	15.66%	28.72%
% of Gross Profit	4.44%	4.35%
Operating Expenses	$1.007B	$1.036B
YoY Change	18.38%	16.75%
Operating Profit	$424.1M	$395.4M
YoY Change	-8.85%	-17.5%
Interest Expense	-$141.1M	-$137.8M
YoY Change	43.98%	72.68%
% of Operating Profit	-33.27%	-34.85%
Other Income/Expense, Net	$5.100M	$27.00M
YoY Change	-196.23%	145.45%
Pretax Income	$288.2M	$282.8M
YoY Change	-20.23%	-30.52%
Income Tax	$65.30M	$66.20M
% Of Pretax Income	22.66%	23.41%
Net Earnings	$209.1M	$214.2M
YoY Change	-20.04%	-27.93%
Net Earnings / Revenue	2.27%	2.32%
Basic Earnings Per Share	$7.82	$7.88
Diluted Earnings Per Share	$7.80	$7.88
COMMON SHARES
Basic Shares Outstanding	26.74M shares	27.41M shares
Diluted Shares Outstanding	26.80M shares	27.20M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$209.8M	$516.4M
YoY Change	-18.05%	158.59%
Cash & Equivalents	$209.8M	$516.4M
Short-Term Investments
Other Short-Term Assets	$224.0M	$194.8M
YoY Change	41.59%	48.93%
Inventory	$6.100B	$6.243B
Prepaid Expenses
Receivables	$1.209B	$1.243B
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$7.893B	$8.355B
YoY Change	35.66%	52.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.387B	$5.339B
YoY Change	21.87%	36.64%
Goodwill	$2.126B	$2.118B
YoY Change	23.22%	31.54%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.515B	$1.200B
YoY Change	43.44%	-32.27%
Total Long-Term Assets	$15.37B	$14.85B
YoY Change	23.43%	21.83%
TOTAL ASSETS
Total Short-Term Assets	$7.893B	$8.355B
Total Long-Term Assets	$15.37B	$14.85B
Total Assets	$23.26B	$23.21B
YoY Change	27.32%	31.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$301.3M	$380.4M
YoY Change	-1.95%	27.78%
Accrued Expenses	$1.120B	$1.198B
YoY Change	28.38%	39.53%
Deferred Revenue
YoY Change
Short-Term Debt	$5.120B	$5.288B
YoY Change	63.83%	87.72%
Long-Term Debt Due	$123.5M	$154.3M
YoY Change	73.94%	104.64%
Total Short-Term Liabilities	$6.664B	$7.020B
YoY Change	52.31%	73.41%
LONG-TERM LIABILITIES
Long-Term Debt	$8.173B	$8.034B
YoY Change	24.03%	21.49%
Other Long-Term Liabilities	$304.3M	$287.6M
YoY Change	25.07%	-76.41%
Total Long-Term Liabilities	$304.3M	$287.6M
YoY Change	25.07%	-96.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.664B	$7.020B
Total Long-Term Liabilities	$304.3M	$287.6M
Total Liabilities	$16.63B	$16.77B
YoY Change	36.31%	41.13%
SHAREHOLDERS EQUITY
Retained Earnings	$5.557B	$5.362B
YoY Change	15.44%	17.43%
Common Stock	$972.6M	$1.004B
YoY Change	-18.79%	-14.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.605B	$6.368B
YoY Change
Total Liabilities & Shareholders Equity	$23.26B	$23.21B
YoY Change	27.32%	31.23%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	$209.1M	$214.2M
YoY Change	-20.04%	-27.93%
Depreciation, Depletion And Amortization	$63.50M	$62.30M
YoY Change	15.66%	28.72%
Cash From Operating Activities	$219.3M	-$148.4M
YoY Change	80.49%	-40.57%
INVESTING ACTIVITIES
Capital Expenditures	$62.20M	$130.1M
YoY Change	-6.61%	123.54%
Acquisitions
YoY Change
Other Investing Activities	-$243.5M	-$119.1M
YoY Change	40.35%	-77.45%
Cash From Investing Activities	-$305.7M	-$249.2M
YoY Change	27.32%	-57.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-237.4M	672.6M
YoY Change	-233.0%	-8.94%
NET CHANGE
Cash From Operating Activities	219.3M	-148.4M
Cash From Investing Activities	-305.7M	-249.2M
Cash From Financing Activities	-237.4M	672.6M
Net Change In Cash	-323.8M	275.0M
YoY Change	-640.57%	-382.34%
FREE CASH FLOW
Cash From Operating Activities	$219.3M	-$148.4M
Capital Expenditures	$62.20M	$130.1M
Free Cash Flow	$157.1M	-$278.5M
YoY Change	186.16%	-9.55%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Profit Loss ProfitLoss	381500000	usd
CY2024Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	46200000	usd
CY2023Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	43000000.0	usd
CY2024Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	46200000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	165400000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	100000000.0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	27800000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	19300000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1500000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-100000	usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	100000	usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	8200000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	29700000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	800000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	42000000.0	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	32100000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	2900000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	2800000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	544100000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	350200000	usd
	us-gaap	Increase Decrease In Finance Receivables IncreaseDecreaseInFinanceReceivables	386900000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	62000000.0	usd
	lad	Increase Decrease In Floor Plan Notes Payable IncreaseDecreaseInFloorPlanNotesPayable	-384400000	usd
	lad	Increase Decrease In Floor Plan Notes Payable IncreaseDecreaseInFloorPlanNotesPayable	-58400000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	54400000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-36800000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	69100000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-11000000.0	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2800000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	14700000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	144000000.0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-298700000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	209700000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	97100000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4000000.0	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	800000	usd
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	146800000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	7226600000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	6767900000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	6789100000	usd
	lad	Repayments Of Long Term Debt Scheduled Payments RepaymentsOfLongTermDebtScheduledPayments	18900000	usd
	lad	Repayments Of Long Term Debt Scheduled Payments RepaymentsOfLongTermDebtScheduledPayments	17500000	usd
	lad	Repayments Of Long Term Debt Other Payments RepaymentsOfLongTermDebtOtherPayments	15100000	usd
	lad	Repayments Of Long Term Debt Other Payments RepaymentsOfLongTermDebtOtherPayments	3400000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	10400000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5000000.0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	7800000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	14900000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	217200000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	14500000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	28200000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	25400000	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	11900000	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	14000000.0	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-3100000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-2700000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1117600000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1248500000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3100000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8100000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-256600000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-42300000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	972000000.0	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	271500000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	715400000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	229200000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	715400000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	229200000	usd
	us-gaap	Interest Paid Net InterestPaidNet	357200000	usd
	us-gaap	Interest Paid Net InterestPaidNet	220300000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	113900000	usd
	lad	Cash Paid For Repayments Of Debt Due To Disposal Group CashPaidForRepaymentsOfDebtDueToDisposalGroup	5900000	usd
	lad	Contingent Consideration In Connection With Acquisitions Noncash Activity ContingentConsiderationInConnectionWithAcquisitionsNoncashActivity	0	usd
	lad	Contingent Consideration In Connection With Acquisitions Noncash Activity ContingentConsiderationInConnectionWithAcquisitionsNoncashActivity	7300000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	868100000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	453700000	usd
	lad	Acquisition Of Finance Leases In Connection With Acquisitions Noncash Activities AcquisitionOfFinanceLeasesInConnectionWithAcquisitionsNoncashActivities	0	usd
	lad	Acquisition Of Finance Leases In Connection With Acquisitions Noncash Activities AcquisitionOfFinanceLeasesInConnectionWithAcquisitionsNoncashActivities	45000000.0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	304000000.0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	135100000	usd
CY2023Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	43000000.0	usd
	us-gaap	Profit Loss ProfitLoss	530700000	usd
	us-gaap	Increase Decrease In Finance Receivables IncreaseDecreaseInFinanceReceivables	684600000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	7049200000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	179800000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	13800000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	117900000	usd
	lad	Cash Paid For Repayments Of Debt Due To Disposal Group CashPaidForRepaymentsOfDebtDueToDisposalGroup	3200000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	46400000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	31800000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-8600000	usd
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	11100000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1169500000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	978500000	usd
	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	6900000	usd
	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	85700000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1515100000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1000200000	usd
	lad	Repayments Borrowings On Floor Plan Notes Payable Net Non Trade RepaymentsBorrowingsOnFloorPlanNotesPayableNetNonTrade	444500000	usd
	lad	Repayments Borrowings On Floor Plan Notes Payable Net Non Trade RepaymentsBorrowingsOnFloorPlanNotesPayableNetNonTrade	223500000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	418800000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	211500000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	739000000.0	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1036400000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	516400000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	88700000	usd
CY2024Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	158400000	usd
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	111000000.0	usd
CY2024Q2	lad	Cash Restricted Cash And Cash Equivalents CashRestrictedCashAndCashEquivalents	674800000	usd
CY2023Q2	lad	Cash Restricted Cash And Cash Equivalents CashRestrictedCashAndCashEquivalents	199700000	usd
CY2024Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	40600000	usd
CY2023Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	29500000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div><span style="color:#00497f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications of amounts previously reported have been made to the accompanying Consolidated Financial Statements to maintain consistency and comparability between periods presented. Within our financing operations income, we disaggregated our “lease income” out of our previously reported “interest, fee, and lease income” to be its own separately presented line item.</span></div>
CY2024Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1245500000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1130200000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2600000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7100000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1242900000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1123100000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	6242900000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4753900000	usd
CY2024Q2	lad	Floor Plan Notes Payable FloorPlanNotesPayable	2590100000	usd
CY2023Q4	lad	Floor Plan Notes Payable FloorPlanNotesPayable	1347000000	usd
CY2024Q2	lad	Floor Plan Notes Payable Non Trade FloorPlanNotesPayableNonTrade	2697400000	usd
CY2023Q4	lad	Floor Plan Notes Payable Non Trade FloorPlanNotesPayableNonTrade	2288500000	usd
CY2024Q2	lad	Floor Plan Debt FloorPlanDebt	5287500000	usd
CY2023Q4	lad	Floor Plan Debt FloorPlanDebt	3635500000	usd
CY2024Q2	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Noncurrent FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossNoncurrent	3739700000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Noncurrent FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossNoncurrent	3348700000	usd
CY2024Q2	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Noncurrent FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestNoncurrent	115800000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Noncurrent FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestNoncurrent	106400000	usd
CY2024Q2	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Noncurrent FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent	3623900000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Noncurrent FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent	3242300000	usd
CY2024Q2	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Noncurrent FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossNoncurrent	3739700000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Noncurrent FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossNoncurrent	3348700000	usd
CY2024Q2	us-gaap	Financing Receivable Threshold Period Past Due FinancingReceivableThresholdPeriodPastDue	P120D
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Noncurrent FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestNoncurrent	106400000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Noncurrent FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestNoncurrent	69300000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff	65600000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff	50100000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery	30100000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery	23600000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Loan Sold FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossLoanSold	300000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Loan Sold FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossLoanSold	0	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date FinancingReceivableExcludingAccruedInterestPurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate	0	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date FinancingReceivableExcludingAccruedInterestPurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate	2300000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	45200000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	52000000.0	usd
CY2024Q2	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Noncurrent FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestNoncurrent	115800000	usd
CY2023Q2	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Noncurrent FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestNoncurrent	97100000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearWriteoff	600000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearWriteoff	0	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff	27400000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff	800000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff	26200000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff	31000000.0	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff	9100000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff	15800000	usd
	lad	Financing Receivable Excluding Accrued Interest Other Financing Receivables Writeoff FinancingReceivableExcludingAccruedInterestOtherFinancingReceivablesWriteoff	2300000	usd
	lad	Financing Receivable Excluding Accrued Interest Other Financing Receivables Writeoff FinancingReceivableExcludingAccruedInterestOtherFinancingReceivablesWriteoff	2500000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff	65600000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff	50100000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1460700000	usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	519100000	usd
CY2023	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	51100000	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	1900000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1930600000	usd
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	47600000	usd
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	142700000	usd
	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	400000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-2400000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	2118100000	usd
CY2024Q2	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	2100000	usd
CY2024Q2	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	0.0	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	200000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	49800000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	500000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	49300000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	4900000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	31800000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	12600000	usd
CY2024Q2	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2024Q2	lad	Net Investment In Operating Leases Gross NetInvestmentInOperatingLeasesGross	308600000	usd
CY2023Q4	lad	Net Investment In Operating Leases Gross NetInvestmentInOperatingLeasesGross	102700000	usd
CY2024Q2	lad	Net Investment In Operating Leases Accumulated Depreciation NetInvestmentInOperatingLeasesAccumulatedDepreciation	20500000	usd
CY2023Q4	lad	Net Investment In Operating Leases Accumulated Depreciation NetInvestmentInOperatingLeasesAccumulatedDepreciation	11200000	usd
CY2024Q2	lad	Net Investment In Operating Leases NetInvestmentInOperatingLeases	288100000	usd
CY2023Q4	lad	Net Investment In Operating Leases NetInvestmentInOperatingLeases	91500000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	394400000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	317000000.0	usd
CY2024Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	18200000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	36500000	usd
CY2024Q2	lad	Lessee Operating Lease Option To Renew LesseeOperatingLeaseOptionToRenew	1	option
CY2024Q1	us-gaap	Defined Benefit Plan Benefit Obligation Period Increase Decrease DefinedBenefitPlanBenefitObligationPeriodIncreaseDecrease	465700000	usd
CY2024Q1	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	466400000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	5600000	usd
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	13200000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	6200000	usd
	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	14400000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	-600000	usd
	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	-1200000	usd
	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	13800000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Expected Future Employer Contributions Remainder Of Fiscal Year DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear	2200000	usd
CY2024Q2	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	350000000	usd
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	788569	shares
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	256.25
CY2024Q2	lad	Cumulative Stock Repurchases Shares CumulativeStockRepurchasesShares	7836079	shares
CY2024Q2	lad	Cumulative Stock Repurchases Average Purchase Price Per Share CumulativeStockRepurchasesAveragePurchasePricePerShare	183.14
CY2024Q2	us-gaap	Share Repurchase Program Excise Tax ShareRepurchaseProgramExciseTax	1500000	usd
	us-gaap	Share Repurchase Program Excise Tax ShareRepurchaseProgramExciseTax	1500000	usd
CY2024Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	614900000	usd
CY2024Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1800000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	9500000	usd
CY2023Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	4500000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	5700000	usd
CY2024Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	9276300000	usd
CY2023Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	9496400000	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	18361900000	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	17753000000	usd
CY2024Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	218400000	usd
CY2023Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	324600000	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	391100000	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	572200000	usd
CY2024Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	8.03
CY2023Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	11.79
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	14.29
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	20.80
CY2024Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	8.02
CY2023Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	11.77
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	14.27
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	20.76
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	214200000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	297200000	usd
	us-gaap	Net Income Loss NetIncomeLoss	376700000	usd
	us-gaap	Net Income Loss NetIncomeLoss	525900000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27200000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27500000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27400000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27500000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	100000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	100000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27200000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27600000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27400000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27600000	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	7.88
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	10.79
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	13.77
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	19.11
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	7.87
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	10.78
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	13.75
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	19.08
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	282800000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	407000000.0	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	503300000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	721300000	usd
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
lad-20240630_cal.xml	Edgar Link	unprocessable
0001023128-24-000104-index-headers.html	Edgar Link	pending
0001023128-24-000104-index.html	Edgar Link	pending
0001023128-24-000104.txt	Edgar Link	pending
0001023128-24-000104-xbrl.zip	Edgar Link	pending
a2024q2ex311ceocertificati.htm	Edgar Link	pending
a2024q2ex312cfocertificati.htm	Edgar Link	pending
a2024q2ex321ceocertificati.htm	Edgar Link	pending
a2024q2ex322cfocertificati.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lad-20240630.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
lad-20240630.xsd	Edgar Link	pending
lad-20240630_g1.jpg	Edgar Link	pending
lad-20240630_g10.jpg	Edgar Link	pending
lad-20240630_g2.jpg	Edgar Link	pending
lad-20240630_g3.jpg	Edgar Link	pending
lad-20240630_g4.jpg	Edgar Link	pending
lad-20240630_g5.jpg	Edgar Link	pending
lad-20240630_g6.jpg	Edgar Link	pending
lad-20240630_g7.jpg	Edgar Link	pending
lad-20240630_g8.jpg	Edgar Link	pending
lad-20240630_g9.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
lad-20240630_def.xml	Edgar Link	unprocessable
lad-20240630_lab.xml	Edgar Link	unprocessable
lad-20240630_pre.xml	Edgar Link	unprocessable
lad-20240630_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
redacted-lithiaxscotiase.htm	Edgar Link	pending
redacted-lithiaxscotiase001.jpg	Edgar Link	pending
redacted-lithiaxscotiase002.jpg	Edgar Link	pending
redacted-lithiaxscotiase003.jpg	Edgar Link	pending
redacted-lithiaxscotiase004.jpg	Edgar Link	pending
redacted-lithiaxscotiase005.jpg	Edgar Link	pending
redacted-lithiaxscotiase006.jpg	Edgar Link	pending
redacted-lithiaxscotiase007.jpg	Edgar Link	pending
redacted-lithiaxscotiase008.jpg	Edgar Link	pending
redacted-lithiaxscotiase009.jpg	Edgar Link	pending
redacted-lithiaxscotiase010.jpg	Edgar Link	pending
redacted-lithiaxscotiase011.jpg	Edgar Link	pending
redacted-lithiaxscotiase012.jpg	Edgar Link	pending
redacted-lithiaxscotiase013.jpg	Edgar Link	pending
redacted-lithiaxscotiase014.jpg	Edgar Link	pending
redacted-lithiaxscotiase015.jpg	Edgar Link	pending
redacted-lithiaxscotiase016.jpg	Edgar Link	pending
redacted-lithiaxscotiase017.jpg	Edgar Link	pending
redacted-lithiaxscotiase018.jpg	Edgar Link	pending
redacted-lithiaxscotiase019.jpg	Edgar Link	pending
redacted-lithiaxscotiase020.jpg	Edgar Link	pending
redacted-lithiaxscotiase021.jpg	Edgar Link	pending
redacted-lithiaxscotiase022.jpg	Edgar Link	pending
redacted-lithiaxscotiase023.jpg	Edgar Link	pending
redacted-lithiaxscotiase024.jpg	Edgar Link	pending
redacted-lithiaxscotiase025.jpg	Edgar Link	pending
redacted-lithiaxscotiase026.jpg	Edgar Link	pending
redacted-lithiaxscotiase027.jpg	Edgar Link	pending
redacted-lithiaxscotiase028.jpg	Edgar Link	pending
redacted-lithiaxscotiase029.jpg	Edgar Link	pending
redacted-lithiaxscotiase030.jpg	Edgar Link	pending
redacted-lithiaxscotiase031.jpg	Edgar Link	pending
redacted-lithiaxscotiase032.jpg	Edgar Link	pending
redacted-lithiaxscotiase033.jpg	Edgar Link	pending
redacted-lithiaxscotiase034.jpg	Edgar Link	pending
redacted-lithiaxscotiase035.jpg	Edgar Link	pending
redacted-lithiaxscotiase036.jpg	Edgar Link	pending
redacted-lithiaxscotiase037.jpg	Edgar Link	pending
redacted-lithiaxscotiase038.jpg	Edgar Link	pending
redacted-lithiaxscotiase039.jpg	Edgar Link	pending
redacted-lithiaxscotiase040.jpg	Edgar Link	pending
redacted-lithiaxscotiase041.jpg	Edgar Link	pending
redacted-lithiaxscotiase042.jpg	Edgar Link	pending
redacted-lithiaxscotiase043.jpg	Edgar Link	pending
redacted-lithiaxscotiase044.jpg	Edgar Link	pending
redacted-lithiaxscotiase045.jpg	Edgar Link	pending
redacted-lithiaxscotiase046.jpg	Edgar Link	pending
redacted-lithiaxscotiase047.jpg	Edgar Link	pending
redacted-lithiaxscotiase048.jpg	Edgar Link	pending
redacted-lithiaxscotiase049.jpg	Edgar Link	pending
redacted-lithiaxscotiase050.jpg	Edgar Link	pending
redacted-lithiaxscotiase051.jpg	Edgar Link	pending
redacted-lithiaxscotiase052.jpg	Edgar Link	pending
redacted-lithiaxscotiase053.jpg	Edgar Link	pending
redacted-lithiaxscotiase054.jpg	Edgar Link	pending
redacted-lithiaxscotiase055.jpg	Edgar Link	pending
redacted-lithiaxscotiase056.jpg	Edgar Link	pending
redacted-lithiaxscotiase057.jpg	Edgar Link	pending
redacted-lithiaxscotiase058.jpg	Edgar Link	pending
redacted-lithiaxscotiase059.jpg	Edgar Link	pending
redacted-lithiaxscotiase060.jpg	Edgar Link	pending
redacted-lithiaxscotiase061.jpg	Edgar Link	pending
redacted-lithiaxscotiase062.jpg	Edgar Link	pending
redacted-lithiaxscotiase063.jpg	Edgar Link	pending
redacted-lithiaxscotiase064.jpg	Edgar Link	pending
redacted-lithiaxscotiase065.jpg	Edgar Link	pending
redacted-lithiaxscotiase066.jpg	Edgar Link	pending
redacted-lithiaxscotiase067.jpg	Edgar Link	pending
redacted-lithiaxscotiase068.jpg	Edgar Link	pending
redacted-lithiaxscotiase069.jpg	Edgar Link	pending
redacted-lithiaxscotiase070.jpg	Edgar Link	pending
redacted-lithiaxscotiase071.jpg	Edgar Link	pending
redacted-lithiaxscotiase072.jpg	Edgar Link	pending
redacted-lithiaxscotiase073.jpg	Edgar Link	pending
redacted-lithiaxscotiase074.jpg	Edgar Link	pending
redacted-lithiaxscotiase075.jpg	Edgar Link	pending
redacted-lithiaxscotiase076.jpg	Edgar Link	pending
redacted-lithiaxscotiase077.jpg	Edgar Link	pending
redacted-lithiaxscotiase078.jpg	Edgar Link	pending
redacted-lithiaxscotiase079.jpg	Edgar Link	pending
redacted-lithiaxscotiase080.jpg	Edgar Link	pending
redacted-lithiaxscotiase081.jpg	Edgar Link	pending
redacted-lithiaxscotiase082.jpg	Edgar Link	pending
redacted-lithiaxscotiase083.jpg	Edgar Link	pending
redacted-lithiaxscotiase084.jpg	Edgar Link	pending
redacted-lithiaxscotiase085.jpg	Edgar Link	pending
redacted-lithiaxscotiase086.jpg	Edgar Link	pending
redacted-lithiaxscotiase087.jpg	Edgar Link	pending
redacted-lithiaxscotiase088.jpg	Edgar Link	pending
redacted-lithiaxscotiase089.jpg	Edgar Link	pending
redacted-lithiaxscotiase090.jpg	Edgar Link	pending
redacted-lithiaxscotiase091.jpg	Edgar Link	pending
redacted-lithiaxscotiase092.jpg	Edgar Link	pending
redacted-lithiaxscotiase093.jpg	Edgar Link	pending
redacted-lithiaxscotiase094.jpg	Edgar Link	pending
redacted-lithiaxscotiase095.jpg	Edgar Link	pending
redacted-lithiaxscotiase096.jpg	Edgar Link	pending
redacted-lithiaxscotiase097.jpg	Edgar Link	pending
redacted-lithiaxscotiase098.jpg	Edgar Link	pending
redacted-lithiaxscotiase099.jpg	Edgar Link	pending
redacted-lithiaxscotiase100.jpg	Edgar Link	pending
redacted-lithiaxscotiase101.jpg	Edgar Link	pending
redacted-lithiaxscotiase102.jpg	Edgar Link	pending
redacted-lithiaxscotiase103.jpg	Edgar Link	pending
redacted-lithiaxscotiase104.jpg	Edgar Link	pending
redacted-lithiaxscotiase105.jpg	Edgar Link	pending
redacted-lithiaxscotiase106.jpg	Edgar Link	pending
redacted-lithiaxscotiase107.jpg	Edgar Link	pending
redacted-lithiaxscotiase108.jpg	Edgar Link	pending
redacted-lithiaxscotiase109.jpg	Edgar Link	pending
redacted-lithiaxscotiase110.jpg	Edgar Link	pending
redacted-lithiaxscotiase111.jpg	Edgar Link	pending
redacted-lithiaxscotiase112.jpg	Edgar Link	pending
redacted-lithiaxscotiase113.jpg	Edgar Link	pending
redacted-lithiaxscotiase114.jpg	Edgar Link	pending
redacted-lithiaxscotiase115.jpg	Edgar Link	pending
redacted-lithiaxscotiase116.jpg	Edgar Link	pending
redacted-lithiaxscotiase117.jpg	Edgar Link	pending
redacted-lithiaxscotiase118.jpg	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LAD
Lithia Motors Inc Stock $lad

2024 Q3 Form 10-Q Financial Statement

#000102312824000104 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LAD Lithia Motors Inc Stock $lad

2024 Q3 Form 10-Q Financial Statement

#000102312824000104 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LAD
Lithia Motors Inc Stock $lad